| Referencias
1. Alaimo K, McDowell MA, Briefel RR, et al. Dietary intake of vitamins, minerals and fiber of persons age 2 months and over in the United States: Third National Health and Nutrition Examination Survey, phase 1, 1988–91. Advance Data from Vital and Health Statistics. 1994;258:1-26.
2. Wester PO. Magnesium. Am J Clin Nutr. 1987;45(suppl):1305–1312.
3. Rude RK. Physiology of Magnesium metabolism and the important role of Magnesium in potassium deficiency. Am J Cardiol. 1989;63:31G–34G.
4 . Hornyak M, Voderholzer U, Hohagen F, et al. Magnesium therapy for periodic leg movements–related insomnia and restless legs syndrome: An open pilot study. Sleep. 1998;21:501–505.
5 . Popoviciu L, Asgian B, Delast-Popoviciu D, et al. Clinical, EEG, electromyographic and polysomnographic studies in restless legs syndrome caused by Magnesium deficiency. Rom J Neurol Psychiatry. 1993;31:55–61.
6 . Martineau J, Barthelemy C, Garreau B. Vitamin B6, Magnesium, and combined B6-Mg: therapeutic effects in childhood autism. Biol Psychiatry. 1985;20:467–478.
7 . Pfeiffer SI, Norton J, Nelson L, et al. Efficacy of vitamin B6 and Magnesium in the treatment of autism: a methodology review and summary of outcomes. J Autism Dev Disord. 1995;25:481–493.
8. Barthelemy C, Garreau B, Leddet I, et al. Behavioral and biological effects of oral Magnesium, vitamin B6 and combined Magnesium –vitamin B6 administration in autistic children. Magnes Bull. 1981;2:150–153.
9. Lelord G, Callaway E, Muh JP. Clinical and biological effects of high doses of vitamin B6 and Magnesium on autistic children. Acta Vitaminol Enzymol. 1982;4:27–44.
10. Lelord G, Muh JP, Barthelemy C. Effects of pyridoxine and Magnesium on autistic symptoms—initial observations. J Autism Dev Disord. 1981;11:219–230.
11. Sibai BM, Villar MA, Bray E. Magnesium supplementation during pregnancy: A double-blind randomized controlled clinical trial. Am J Obstet Gynecol. 1989;161:115–119.
12. De Souza MC, Walker AF, Robinson PA, et al. A synergistic effect of a daily supplement for 1 month of 200 mg Magnesium plus 50 mg vitamin B6 for the relief of anxiety-related premenstrual symptoms: a randomized, double-blind, crossover study. J Womens Health Gend Based Med. 2000;9:131–139.
13. Dahle LO, Berg G, Hammar M, et al. The effect of oral Magnesio substitution on pregnancy-induced leg cramps. Am J Obstet Gynecol. 1995;173:175–180.
14. Wagner J, Wagner ML, Hening WA. Beyond benzodiazepines: alternative pharmacologic agents for the treatment of insomnia. Ann Pharmacother. 1998 Jun;32(6):680-91.
15. Klich, R. And Gladbach, B. Behavior disorders in childhood and their therapy. Medizinische Welt, 26(25), 1252-1254, 1975.
16. Schneider K. [Contribution to the treatment of the "nervous school child" in general practice]. Hippokrates. 1967 Oct 31;38(20):820
17. Leathwood, P.D., Chauffard, F., et al. Aqueous extract of valerian reduces latency to fall asleep in man. Planta Medica, 2, 144-148, 1985.
18. Leathwood, P.D., Chauffard, F., et al. Aqueous extract of valerian root improves sleep quality in man. Pharmacol. Biochem. And Beba., 17, 65-71, 1982
19. Chauffard, F., et al. Detection of mild sedative effects: valerian and sleep in man. Experientia, 37, 662, 1982
20. von Eickstedt, K.S. et. Al. Psychopharmacologic effects of valepotriates. Arzneimittel-Forschung, 19, 316-319, 1969, and 19, 993, 1969
21. Riedel, et al. Inhibition of GABA breackdown by valerenic acid. Planta Medica, 46, 219-220, 1982.
22. Fink, C., The meaning of valerian root in therapy. Therapie der Gegenwart, 107, 555-562, 1968.
23. Kempinskas, V. On the action of valerian. Farmakologiia i Toksikologiia, 4(3), 305-309, 1964.
24. Staube, C. The meaning of valerian root in therapy. Therapie der Gegenwart, 107, 555-562, 1968
25. Boeters U. [Treatment of control disorders of the autonomic nervous system with valepotriate]. Munch Med Wochenschr. 1969 Sep 12;111(37):1873-6
26. Giedke H, Breyer-Pfaff U. Critical evaluation of the effect of valerian extract on sleep structure and sleep quality. Pharmacopsychiatry. 2000 Nov;33(6):239.
27. Fussel A, Wolf A, Brattstrom A. Effect of a fixed valerian-Hop extract combination (Ze 91019) on sleep polygraphy in patients with non-organic insomnia: A pilot study. Eur J Med Res. 2000 Sep 18;5(9):385-90.
28. Dominguez RA, Bravo-Valverde RL, Kaplowitz BR, Cott JM. Valerian as a hypnotic for Hispanic patients. Cultur Divers Ethni Minor Psychol. 2000 Feb;6(1):84-92.
29. Vonderheid-Guth B, Todorova A, Brattstrom A, Dimpfel W. Pharmacodynamic effects of valerian and hops extract combination (Ze 91019) on the quantitative-topographical EEG in healthy volunteers. Eur J Med Res. 2000 Apr 19;5(4):139-44.
30. Donath F, Quispe S, Diefenbach K, Maurer A, Fietze I, Roots I. Critical evaluation of the effect of valerian extract on sleep structure and sleep quality. Pharmacopsychiatry. 2000 Mar;33(2):47-53.
31. Plushner SL. Valerian: Valeriana officinalis. Am J Health Syst Pharm. 2000 Feb 15;57(4):328, 333, 335..
32. Kuhlmann J, Berger W, Podzuweit H, Schmidt U. The influence of valerian treatment on "reaction time, alertness and concentration" in volunteers. Pharmacopsychiatry. 1999 Nov;32(6):235-41.
33. Kirkwood CK. Management of insomnia. J Am Pharm Assoc (Wash). 1999 Sep-Oct;39(5):688-96.
34. Houghton PJ. The scientific basis for the reputed activity of Valerian. J Pharm Pharmacol. 1999 May;51(5):505-12.
35. Schmitz M, Jackel M. [Comparative study for assessing quality of life of patients with exogenous sleep disorders (temporary sleep onset and sleep interruption disorders) treated with a hops-valarian preparation and a benzodiazepine drug]. Wien Med Wochenschr. 1998;148(13):291-8.
36. Cavadas C, Araujo I, Cotrim MD, Amaral T, Cunha AP, Macedo T, Ribeiro CF. In vitro study on the interaction of Valeriana officinalis L. extracts and their amino acids on GABA receptor in rat brain. Arzneimittelforschung. 1995 Jul;45(7):753-5.
37. Santos MS, Ferreira F, Faro C, Pires E, Carvalho AP, Cunha AP, Macedo T. The amount of GABA present in aqueous extracts of valerian is sufficient to account for [3H]GABA release in synaptosomes. Planta Med. 1994 Oct;60(5):475-6.
38. Schulz H, Stolz C, Muller J. The effect of valerian extract on sleep polygraphy in poor sleepers: a pilot study. Pharmacopsychiatry. 1994 Jul;27(4):147-51.
39. Santos MS, Ferreira F, Cunha AP, Carvalho AP, Macedo T. An aqueous extract of valerian influences the transport of GABA in synaptosomes. Planta Med. 1994 Jun;60(3):278-9.
40. Santos MS, Ferreira F, Cunha AP, Carvalho AP, Ribeiro CF, Macedo T. Synaptosomal GABA release as influenced by valerian root extract--involvement of the GABA carrier. Arch Int Pharmacodyn Ther. 1994 Mar-Apr;327(2):220-31.
41. Leuschner J, Muller J, Rudmann M. Characterisation of the central nervous depressant activity of a commercially available valerian root extract. Arzneimittelforschung. 1993 Jun;43(6):638-41.
42. Lindahl O, Lindwall L. Double blind study of a valerian preparation. Pharmacol Biochem Behav. 1989 Apr;32(4):1065-6.
43. de Romanis F, Di Tondo U, Renda F, Sopranzi N. [Superficial and deep EEG recordings of valerian-related drugs]. Clin Ter. 1988 Jul 31;126(2):101-8.
44. Houghton PJ. The biological activity of Valerian and related plants. J Ethnopharmacol. 1988 Feb-Mar;22(2):121-42.
45. Balderer G, Borbely AA. Effect of valerian on human sleep. Psychopharmacology. 1985;87(4):406-9.
46. Leathwood PD, Chauffard F. Quantifying the effects of mild sedatives. J Psychiatr Res. 1982-83;17(2):115-22.
47. Faust V, Hole G.[Disturbed sleep II.: Therapy of sleep disorders]. ZFA (Stuttgart). 1980 Dec 20;56(35-36):2437-59.
48. Wohlfart R.[Radix valerianae. History of an old medical drug, its active substances and their importance in the modern therapy]. Z Allgemeinmed. 1974 Jun 20;50(17):797-800
49. Wagner H, Horhammer L, Holzl J, Schaette R. [Evaluation of Valerian drug and its preparations]. Arzneimittelforschung. 1970 Aug;20(8):1149-52
50. Cavazzuti GB. [Study of the clinical pharmacology of an association of gamma-amino-beta-hydroxybutyric acid and plant extracts used in therapy of children with behavior disorders and sleep disorders]. Clin Ter. 1969 Oct;51(1):15-29.
51. Dymchenko EI. [Therapeutic dose of valerian tincture]. Vrach Delo. 1969 Jul;7:141-2
52. Last G. [On the treatment of insomnia]. Hippokrates. 1969 Jan 15;40(1):28-33
53. Straube G. [The importance of valerian roots in therapy]. Ther Ggw. 1968 Apr;107(4):555-62 |